Global Anti-Obesity Drugs (Anti-obesity Medication) Market Research Report 2026(Status and Outlook)
Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control weight. These medications alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Anti-Obesity Drugs (Anti-obesity Medication) market size was estimated at USD 2506.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 17.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Anti-Obesity Drugs (Anti-obesity Medication) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Anti-Obesity Drugs (Anti-obesity Medication) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Anti-Obesity Drugs (Anti-obesity Medication) market.
Global Anti-Obesity Drugs (Anti-obesity Medication) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Zafgan
Vivus
Shionogi
Sanofi
Rhythm Pharmaceuticals
Pfizer
Orexigen Therapeutics
Novo Nordisk
Norgine
Nalpropion Pharmaceuticals Inc.
Merck
GlaxoSmithKline
F.Hoffmann-La Roche
Eisai
Boehringer Ingelheim
Bayer AG
AstraZeneca
Arena Pharmaceuticals
Amylin
Alizyme
Market Segmentation (by Type)
by Drug Varieties
by Acting
Market Segmentation (by Application)
Childhood (0-6)
Juvenile (7-17)
Youth (18-40)
Middle Aged (41-60)
Elderly (Above 60)
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Anti-Obesity Drugs (Anti-obesity Medication) Market
Overview of the regional outlook of the Anti-Obesity Drugs (Anti-obesity Medication) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-Obesity Drugs (Anti-obesity Medication) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Anti-Obesity Drugs (Anti-obesity Medication), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Anti-Obesity Drugs (Anti-obesity Medication) market size was estimated at USD 2506.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 17.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Anti-Obesity Drugs (Anti-obesity Medication) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Anti-Obesity Drugs (Anti-obesity Medication) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Anti-Obesity Drugs (Anti-obesity Medication) market.
Global Anti-Obesity Drugs (Anti-obesity Medication) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Zafgan
Vivus
Shionogi
Sanofi
Rhythm Pharmaceuticals
Pfizer
Orexigen Therapeutics
Novo Nordisk
Norgine
Nalpropion Pharmaceuticals Inc.
Merck
GlaxoSmithKline
F.Hoffmann-La Roche
Eisai
Boehringer Ingelheim
Bayer AG
AstraZeneca
Arena Pharmaceuticals
Amylin
Alizyme
Market Segmentation (by Type)
by Drug Varieties
by Acting
Market Segmentation (by Application)
Childhood (0-6)
Juvenile (7-17)
Youth (18-40)
Middle Aged (41-60)
Elderly (Above 60)
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Anti-Obesity Drugs (Anti-obesity Medication) Market
Overview of the regional outlook of the Anti-Obesity Drugs (Anti-obesity Medication) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-Obesity Drugs (Anti-obesity Medication) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Anti-Obesity Drugs (Anti-obesity Medication), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Anti-Obesity Drugs (Anti-obesity Medication)
1.2 Key Market Segments
1.2.1 Anti-Obesity Drugs (Anti-obesity Medication) Segment by Type
1.2.2 Anti-Obesity Drugs (Anti-obesity Medication) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Product Life Cycle
3.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Manufacturers (2020-2025)
3.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Manufacturers (2020-2025)
3.5 Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Anti-Obesity Drugs (Anti-obesity Medication) Market Competitive Situation and Trends
3.8.1 Anti-Obesity Drugs (Anti-obesity Medication) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Anti-Obesity Drugs (Anti-obesity Medication) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) INDUSTRY CHAIN ANALYSIS
4.1 Anti-Obesity Drugs (Anti-obesity Medication) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Anti-Obesity Drugs (Anti-obesity Medication) Market
5.7 ESG Ratings of Leading Companies
6 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2020-2025)
6.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type (2020-2025)
6.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2020-2025)
7 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Sales by Application (2020-2025)
7.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) by Application (2020-2025)
7.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Growth Rate by Application (2020-2025)
8 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET SALES BY REGION
8.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
8.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
8.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region
8.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region
8.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region
8.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region
8.3 North America
8.3.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country
8.3.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country
8.4.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
8.5.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country
8.6.2 South America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
8.7.2 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET PRODUCTION BY REGION
9.1 Global Production of Anti-Obesity Drugs (Anti-obesity Medication) by Region(2020-2025)
9.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region (2020-2025)
9.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Anti-Obesity Drugs (Anti-obesity Medication) Production
9.4.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Production Growth Rate (2020-2025)
9.4.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Anti-Obesity Drugs (Anti-obesity Medication) Production
9.5.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Production Growth Rate (2020-2025)
9.5.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Anti-Obesity Drugs (Anti-obesity Medication) Production (2020-2025)
9.6.1 Japan Anti-Obesity Drugs (Anti-obesity Medication) Production Growth Rate (2020-2025)
9.6.2 Japan Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Anti-Obesity Drugs (Anti-obesity Medication) Production (2020-2025)
9.7.1 China Anti-Obesity Drugs (Anti-obesity Medication) Production Growth Rate (2020-2025)
9.7.2 China Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Zafgan
10.1.1 Zafgan Basic Information
10.1.2 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.1.3 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.1.4 Zafgan Business Overview
10.1.5 Zafgan SWOT Analysis
10.1.6 Zafgan Recent Developments
10.2 Vivus
10.2.1 Vivus Basic Information
10.2.2 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.2.3 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.2.4 Vivus Business Overview
10.2.5 Vivus SWOT Analysis
10.2.6 Vivus Recent Developments
10.3 Shionogi
10.3.1 Shionogi Basic Information
10.3.2 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.3.3 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.3.4 Shionogi Business Overview
10.3.5 Shionogi SWOT Analysis
10.3.6 Shionogi Recent Developments
10.4 Sanofi
10.4.1 Sanofi Basic Information
10.4.2 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.4.3 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.4.4 Sanofi Business Overview
10.4.5 Sanofi Recent Developments
10.5 Rhythm Pharmaceuticals
10.5.1 Rhythm Pharmaceuticals Basic Information
10.5.2 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.5.3 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.5.4 Rhythm Pharmaceuticals Business Overview
10.5.5 Rhythm Pharmaceuticals Recent Developments
10.6 Pfizer
10.6.1 Pfizer Basic Information
10.6.2 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.6.3 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.6.4 Pfizer Business Overview
10.6.5 Pfizer Recent Developments
10.7 Orexigen Therapeutics
10.7.1 Orexigen Therapeutics Basic Information
10.7.2 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.7.3 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.7.4 Orexigen Therapeutics Business Overview
10.7.5 Orexigen Therapeutics Recent Developments
10.8 Novo Nordisk
10.8.1 Novo Nordisk Basic Information
10.8.2 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.8.3 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.8.4 Novo Nordisk Business Overview
10.8.5 Novo Nordisk Recent Developments
10.9 Norgine
10.9.1 Norgine Basic Information
10.9.2 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.9.3 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.9.4 Norgine Business Overview
10.9.5 Norgine Recent Developments
10.10 Nalpropion Pharmaceuticals Inc.
10.10.1 Nalpropion Pharmaceuticals Inc. Basic Information
10.10.2 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.10.3 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.10.4 Nalpropion Pharmaceuticals Inc. Business Overview
10.10.5 Nalpropion Pharmaceuticals Inc. Recent Developments
10.11 Merck
10.11.1 Merck Basic Information
10.11.2 Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.11.3 Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.11.4 Merck Business Overview
10.11.5 Merck Recent Developments
10.12 GlaxoSmithKline
10.12.1 GlaxoSmithKline Basic Information
10.12.2 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.12.3 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.12.4 GlaxoSmithKline Business Overview
10.12.5 GlaxoSmithKline Recent Developments
10.13 F.Hoffmann-La Roche
10.13.1 F.Hoffmann-La Roche Basic Information
10.13.2 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.13.3 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.13.4 F.Hoffmann-La Roche Business Overview
10.13.5 F.Hoffmann-La Roche Recent Developments
10.14 Eisai
10.14.1 Eisai Basic Information
10.14.2 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.14.3 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.14.4 Eisai Business Overview
10.14.5 Eisai Recent Developments
10.15 Boehringer Ingelheim
10.15.1 Boehringer Ingelheim Basic Information
10.15.2 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.15.3 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.15.4 Boehringer Ingelheim Business Overview
10.15.5 Boehringer Ingelheim Recent Developments
10.16 Bayer AG
10.16.1 Bayer AG Basic Information
10.16.2 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.16.3 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.16.4 Bayer AG Business Overview
10.16.5 Bayer AG Recent Developments
10.17 AstraZeneca
10.17.1 AstraZeneca Basic Information
10.17.2 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.17.3 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.17.4 AstraZeneca Business Overview
10.17.5 AstraZeneca Recent Developments
10.18 Arena Pharmaceuticals
10.18.1 Arena Pharmaceuticals Basic Information
10.18.2 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.18.3 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.18.4 Arena Pharmaceuticals Business Overview
10.18.5 Arena Pharmaceuticals Recent Developments
10.19 Amylin
10.19.1 Amylin Basic Information
10.19.2 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.19.3 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.19.4 Amylin Business Overview
10.19.5 Amylin Recent Developments
10.20 Alizyme
10.20.1 Alizyme Basic Information
10.20.2 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.20.3 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.20.4 Alizyme Business Overview
10.20.5 Alizyme Recent Developments
11 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET FORECAST BY REGION
11.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast
11.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country
11.2.3 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Region
11.2.4 South America Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Anti-Obesity Drugs (Anti-obesity Medication) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Anti-Obesity Drugs (Anti-obesity Medication) by Type (2026-2035)
12.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Anti-Obesity Drugs (Anti-obesity Medication) by Type (2026-2035)
12.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Forecast by Application (2026-2035)
12.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) Forecast by Application
12.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Anti-Obesity Drugs (Anti-obesity Medication)
1.2 Key Market Segments
1.2.1 Anti-Obesity Drugs (Anti-obesity Medication) Segment by Type
1.2.2 Anti-Obesity Drugs (Anti-obesity Medication) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Product Life Cycle
3.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Manufacturers (2020-2025)
3.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Manufacturers (2020-2025)
3.5 Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Anti-Obesity Drugs (Anti-obesity Medication) Market Competitive Situation and Trends
3.8.1 Anti-Obesity Drugs (Anti-obesity Medication) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Anti-Obesity Drugs (Anti-obesity Medication) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) INDUSTRY CHAIN ANALYSIS
4.1 Anti-Obesity Drugs (Anti-obesity Medication) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Anti-Obesity Drugs (Anti-obesity Medication) Market
5.7 ESG Ratings of Leading Companies
6 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2020-2025)
6.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type (2020-2025)
6.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2020-2025)
7 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Sales by Application (2020-2025)
7.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) by Application (2020-2025)
7.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Growth Rate by Application (2020-2025)
8 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET SALES BY REGION
8.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
8.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
8.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region
8.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region
8.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region
8.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region
8.3 North America
8.3.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country
8.3.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country
8.4.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
8.5.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country
8.6.2 South America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
8.7.2 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET PRODUCTION BY REGION
9.1 Global Production of Anti-Obesity Drugs (Anti-obesity Medication) by Region(2020-2025)
9.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region (2020-2025)
9.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Anti-Obesity Drugs (Anti-obesity Medication) Production
9.4.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Production Growth Rate (2020-2025)
9.4.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Anti-Obesity Drugs (Anti-obesity Medication) Production
9.5.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Production Growth Rate (2020-2025)
9.5.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Anti-Obesity Drugs (Anti-obesity Medication) Production (2020-2025)
9.6.1 Japan Anti-Obesity Drugs (Anti-obesity Medication) Production Growth Rate (2020-2025)
9.6.2 Japan Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Anti-Obesity Drugs (Anti-obesity Medication) Production (2020-2025)
9.7.1 China Anti-Obesity Drugs (Anti-obesity Medication) Production Growth Rate (2020-2025)
9.7.2 China Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Zafgan
10.1.1 Zafgan Basic Information
10.1.2 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.1.3 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.1.4 Zafgan Business Overview
10.1.5 Zafgan SWOT Analysis
10.1.6 Zafgan Recent Developments
10.2 Vivus
10.2.1 Vivus Basic Information
10.2.2 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.2.3 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.2.4 Vivus Business Overview
10.2.5 Vivus SWOT Analysis
10.2.6 Vivus Recent Developments
10.3 Shionogi
10.3.1 Shionogi Basic Information
10.3.2 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.3.3 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.3.4 Shionogi Business Overview
10.3.5 Shionogi SWOT Analysis
10.3.6 Shionogi Recent Developments
10.4 Sanofi
10.4.1 Sanofi Basic Information
10.4.2 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.4.3 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.4.4 Sanofi Business Overview
10.4.5 Sanofi Recent Developments
10.5 Rhythm Pharmaceuticals
10.5.1 Rhythm Pharmaceuticals Basic Information
10.5.2 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.5.3 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.5.4 Rhythm Pharmaceuticals Business Overview
10.5.5 Rhythm Pharmaceuticals Recent Developments
10.6 Pfizer
10.6.1 Pfizer Basic Information
10.6.2 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.6.3 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.6.4 Pfizer Business Overview
10.6.5 Pfizer Recent Developments
10.7 Orexigen Therapeutics
10.7.1 Orexigen Therapeutics Basic Information
10.7.2 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.7.3 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.7.4 Orexigen Therapeutics Business Overview
10.7.5 Orexigen Therapeutics Recent Developments
10.8 Novo Nordisk
10.8.1 Novo Nordisk Basic Information
10.8.2 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.8.3 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.8.4 Novo Nordisk Business Overview
10.8.5 Novo Nordisk Recent Developments
10.9 Norgine
10.9.1 Norgine Basic Information
10.9.2 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.9.3 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.9.4 Norgine Business Overview
10.9.5 Norgine Recent Developments
10.10 Nalpropion Pharmaceuticals Inc.
10.10.1 Nalpropion Pharmaceuticals Inc. Basic Information
10.10.2 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.10.3 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.10.4 Nalpropion Pharmaceuticals Inc. Business Overview
10.10.5 Nalpropion Pharmaceuticals Inc. Recent Developments
10.11 Merck
10.11.1 Merck Basic Information
10.11.2 Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.11.3 Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.11.4 Merck Business Overview
10.11.5 Merck Recent Developments
10.12 GlaxoSmithKline
10.12.1 GlaxoSmithKline Basic Information
10.12.2 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.12.3 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.12.4 GlaxoSmithKline Business Overview
10.12.5 GlaxoSmithKline Recent Developments
10.13 F.Hoffmann-La Roche
10.13.1 F.Hoffmann-La Roche Basic Information
10.13.2 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.13.3 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.13.4 F.Hoffmann-La Roche Business Overview
10.13.5 F.Hoffmann-La Roche Recent Developments
10.14 Eisai
10.14.1 Eisai Basic Information
10.14.2 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.14.3 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.14.4 Eisai Business Overview
10.14.5 Eisai Recent Developments
10.15 Boehringer Ingelheim
10.15.1 Boehringer Ingelheim Basic Information
10.15.2 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.15.3 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.15.4 Boehringer Ingelheim Business Overview
10.15.5 Boehringer Ingelheim Recent Developments
10.16 Bayer AG
10.16.1 Bayer AG Basic Information
10.16.2 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.16.3 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.16.4 Bayer AG Business Overview
10.16.5 Bayer AG Recent Developments
10.17 AstraZeneca
10.17.1 AstraZeneca Basic Information
10.17.2 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.17.3 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.17.4 AstraZeneca Business Overview
10.17.5 AstraZeneca Recent Developments
10.18 Arena Pharmaceuticals
10.18.1 Arena Pharmaceuticals Basic Information
10.18.2 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.18.3 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.18.4 Arena Pharmaceuticals Business Overview
10.18.5 Arena Pharmaceuticals Recent Developments
10.19 Amylin
10.19.1 Amylin Basic Information
10.19.2 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.19.3 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.19.4 Amylin Business Overview
10.19.5 Amylin Recent Developments
10.20 Alizyme
10.20.1 Alizyme Basic Information
10.20.2 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.20.3 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.20.4 Alizyme Business Overview
10.20.5 Alizyme Recent Developments
11 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET FORECAST BY REGION
11.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast
11.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country
11.2.3 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Region
11.2.4 South America Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Anti-Obesity Drugs (Anti-obesity Medication) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Anti-Obesity Drugs (Anti-obesity Medication) by Type (2026-2035)
12.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Anti-Obesity Drugs (Anti-obesity Medication) by Type (2026-2035)
12.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Forecast by Application (2026-2035)
12.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) Forecast by Application
12.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type (M USD)
Table 4. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
Table 5. Anti-Obesity Drugs (Anti-obesity Medication) Market Size Comparison by Region (M USD)
Table 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Obesity Drugs (Anti-obesity Medication) as of 2025)
Table 11. Global Market Anti-Obesity Drugs (Anti-obesity Medication) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Anti-Obesity Drugs (Anti-obesity Medication) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-Obesity Drugs (Anti-obesity Medication) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (K MT)
Table 27. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type (M USD)
Table 28. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) by Type (2020-2025)
Table 29. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2020-2025)
Table 30. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) by Type (2020-2025)
Table 31. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Type (2020-2025)
Table 32. Global Anti-Obesity Drugs (Anti-obesity Medication) Price (USD/KG) by Type (2020-2025)
Table 33. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) by Application
Table 34. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
Table 35. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2020-2025) & (K MT)
Table 36. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2020-2025)
Table 37. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Application (2020-2025)
Table 39. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Growth Rate by Application (2020-2025)
Table 40. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2020-2025) & (K MT)
Table 41. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2020-2025)
Table 42. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region (2020-2025)
Table 44. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2020-2025) & (K MT)
Table 45. North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2020-2025) & (K MT)
Table 47. Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2020-2025) & (K MT)
Table 51. South America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) by Region(2020-2025)
Table 55. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region (2020-2025)
Table 57. Global Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Zafgan Basic Information
Table 63. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 64. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Zafgan Business Overview
Table 66. Zafgan SWOT Analysis
Table 67. Zafgan Recent Developments
Table 68. Vivus Basic Information
Table 69. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 70. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Vivus Business Overview
Table 72. Vivus SWOT Analysis
Table 73. Vivus Recent Developments
Table 74. Shionogi Basic Information
Table 75. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 76. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Shionogi Business Overview
Table 78. Shionogi SWOT Analysis
Table 79. Shionogi Recent Developments
Table 80. Sanofi Basic Information
Table 81. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 82. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sanofi Business Overview
Table 84. Sanofi Recent Developments
Table 85. Rhythm Pharmaceuticals Basic Information
Table 86. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 87. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Rhythm Pharmaceuticals Business Overview
Table 89. Rhythm Pharmaceuticals Recent Developments
Table 90. Pfizer Basic Information
Table 91. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 92. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Pfizer Business Overview
Table 94. Pfizer Recent Developments
Table 95. Orexigen Therapeutics Basic Information
Table 96. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 97. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Orexigen Therapeutics Business Overview
Table 99. Orexigen Therapeutics Recent Developments
Table 100. Novo Nordisk Basic Information
Table 101. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 102. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Novo Nordisk Business Overview
Table 104. Novo Nordisk Recent Developments
Table 105. Norgine Basic Information
Table 106. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 107. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Norgine Business Overview
Table 109. Norgine Recent Developments
Table 110. Nalpropion Pharmaceuticals Inc. Basic Information
Table 111. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 112. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Nalpropion Pharmaceuticals Inc. Business Overview
Table 114. Nalpropion Pharmaceuticals Inc. Recent Developments
Table 115. Merck Basic Information
Table 116. Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 117. Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Merck Business Overview
Table 119. Merck Recent Developments
Table 120. GlaxoSmithKline Basic Information
Table 121. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 122. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. GlaxoSmithKline Business Overview
Table 124. GlaxoSmithKline Recent Developments
Table 125. F.Hoffmann-La Roche Basic Information
Table 126. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 127. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. F.Hoffmann-La Roche Business Overview
Table 129. F.Hoffmann-La Roche Recent Developments
Table 130. Eisai Basic Information
Table 131. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 132. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Eisai Business Overview
Table 134. Eisai Recent Developments
Table 135. Boehringer Ingelheim Basic Information
Table 136. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 137. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Boehringer Ingelheim Business Overview
Table 139. Boehringer Ingelheim Recent Developments
Table 140. Bayer AG Basic Information
Table 141. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 142. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Bayer AG Business Overview
Table 144. Bayer AG Recent Developments
Table 145. AstraZeneca Basic Information
Table 146. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 147. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. AstraZeneca Business Overview
Table 149. AstraZeneca Recent Developments
Table 150. Arena Pharmaceuticals Basic Information
Table 151. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 152. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Arena Pharmaceuticals Business Overview
Table 154. Arena Pharmaceuticals Recent Developments
Table 155. Amylin Basic Information
Table 156. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 157. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Amylin Business Overview
Table 159. Amylin Recent Developments
Table 160. Alizyme Basic Information
Table 161. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 162. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Alizyme Business Overview
Table 164. Alizyme Recent Developments
Table 165. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Region (2026-2035) & (K MT)
Table 166. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Country (2026-2035) & (K MT)
Table 168. North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Country (2026-2035) & (K MT)
Table 170. Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Region (2026-2035) & (K MT)
Table 172. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Country (2026-2035) & (K MT)
Table 174. South America Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Type (2026-2035) & (K MT)
Table 178. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global Anti-Obesity Drugs (Anti-obesity Medication) Price Forecast by Type (2026-2035) & (USD/KG)
Table 180. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) Forecast by Application (2026-2035)
Table 181. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type (M USD)
Table 4. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
Table 5. Anti-Obesity Drugs (Anti-obesity Medication) Market Size Comparison by Region (M USD)
Table 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Obesity Drugs (Anti-obesity Medication) as of 2025)
Table 11. Global Market Anti-Obesity Drugs (Anti-obesity Medication) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Anti-Obesity Drugs (Anti-obesity Medication) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-Obesity Drugs (Anti-obesity Medication) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (K MT)
Table 27. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type (M USD)
Table 28. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) by Type (2020-2025)
Table 29. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2020-2025)
Table 30. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) by Type (2020-2025)
Table 31. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Type (2020-2025)
Table 32. Global Anti-Obesity Drugs (Anti-obesity Medication) Price (USD/KG) by Type (2020-2025)
Table 33. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) by Application
Table 34. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
Table 35. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2020-2025) & (K MT)
Table 36. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2020-2025)
Table 37. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Application (2020-2025)
Table 39. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Growth Rate by Application (2020-2025)
Table 40. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2020-2025) & (K MT)
Table 41. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2020-2025)
Table 42. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region (2020-2025)
Table 44. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2020-2025) & (K MT)
Table 45. North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2020-2025) & (K MT)
Table 47. Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2020-2025) & (K MT)
Table 51. South America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) by Region(2020-2025)
Table 55. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region (2020-2025)
Table 57. Global Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Zafgan Basic Information
Table 63. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 64. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Zafgan Business Overview
Table 66. Zafgan SWOT Analysis
Table 67. Zafgan Recent Developments
Table 68. Vivus Basic Information
Table 69. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 70. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Vivus Business Overview
Table 72. Vivus SWOT Analysis
Table 73. Vivus Recent Developments
Table 74. Shionogi Basic Information
Table 75. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 76. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Shionogi Business Overview
Table 78. Shionogi SWOT Analysis
Table 79. Shionogi Recent Developments
Table 80. Sanofi Basic Information
Table 81. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 82. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sanofi Business Overview
Table 84. Sanofi Recent Developments
Table 85. Rhythm Pharmaceuticals Basic Information
Table 86. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 87. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Rhythm Pharmaceuticals Business Overview
Table 89. Rhythm Pharmaceuticals Recent Developments
Table 90. Pfizer Basic Information
Table 91. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 92. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Pfizer Business Overview
Table 94. Pfizer Recent Developments
Table 95. Orexigen Therapeutics Basic Information
Table 96. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 97. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Orexigen Therapeutics Business Overview
Table 99. Orexigen Therapeutics Recent Developments
Table 100. Novo Nordisk Basic Information
Table 101. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 102. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Novo Nordisk Business Overview
Table 104. Novo Nordisk Recent Developments
Table 105. Norgine Basic Information
Table 106. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 107. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Norgine Business Overview
Table 109. Norgine Recent Developments
Table 110. Nalpropion Pharmaceuticals Inc. Basic Information
Table 111. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 112. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Nalpropion Pharmaceuticals Inc. Business Overview
Table 114. Nalpropion Pharmaceuticals Inc. Recent Developments
Table 115. Merck Basic Information
Table 116. Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 117. Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Merck Business Overview
Table 119. Merck Recent Developments
Table 120. GlaxoSmithKline Basic Information
Table 121. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 122. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. GlaxoSmithKline Business Overview
Table 124. GlaxoSmithKline Recent Developments
Table 125. F.Hoffmann-La Roche Basic Information
Table 126. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 127. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. F.Hoffmann-La Roche Business Overview
Table 129. F.Hoffmann-La Roche Recent Developments
Table 130. Eisai Basic Information
Table 131. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 132. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Eisai Business Overview
Table 134. Eisai Recent Developments
Table 135. Boehringer Ingelheim Basic Information
Table 136. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 137. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Boehringer Ingelheim Business Overview
Table 139. Boehringer Ingelheim Recent Developments
Table 140. Bayer AG Basic Information
Table 141. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 142. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Bayer AG Business Overview
Table 144. Bayer AG Recent Developments
Table 145. AstraZeneca Basic Information
Table 146. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 147. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. AstraZeneca Business Overview
Table 149. AstraZeneca Recent Developments
Table 150. Arena Pharmaceuticals Basic Information
Table 151. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 152. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Arena Pharmaceuticals Business Overview
Table 154. Arena Pharmaceuticals Recent Developments
Table 155. Amylin Basic Information
Table 156. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 157. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Amylin Business Overview
Table 159. Amylin Recent Developments
Table 160. Alizyme Basic Information
Table 161. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 162. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Alizyme Business Overview
Table 164. Alizyme Recent Developments
Table 165. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Region (2026-2035) & (K MT)
Table 166. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Country (2026-2035) & (K MT)
Table 168. North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Country (2026-2035) & (K MT)
Table 170. Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Region (2026-2035) & (K MT)
Table 172. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Country (2026-2035) & (K MT)
Table 174. South America Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Type (2026-2035) & (K MT)
Table 178. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global Anti-Obesity Drugs (Anti-obesity Medication) Price Forecast by Type (2026-2035) & (USD/KG)
Table 180. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) Forecast by Application (2026-2035)
Table 181. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Anti-Obesity Drugs (Anti-obesity Medication)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD), 2025-2035
Figure 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) (2020-2035)
Figure 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Anti-Obesity Drugs (Anti-obesity Medication) Product Life Cycle
Figure 13. Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Manufacturers in 2025
Figure 14. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Manufacturers in 2025
Figure 15. Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Anti-Obesity Drugs (Anti-obesity Medication) Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Anti-Obesity Drugs (Anti-obesity Medication) Revenue in 2025
Figure 18. Industry Chain Map of Anti-Obesity Drugs (Anti-obesity Medication)
Figure 19. Global Anti-Obesity Drugs (Anti-obesity Medication) Market PEST Analysis
Figure 20. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Type
Figure 27. Sales Market Share of Anti-Obesity Drugs (Anti-obesity Medication) by Type (2020-2025)
Figure 28. Sales Market Share of Anti-Obesity Drugs (Anti-obesity Medication) by Type in 2025
Figure 29. Market Share of Anti-Obesity Drugs (Anti-obesity Medication) by Type (2020-2025)
Figure 30. Market Share of Anti-Obesity Drugs (Anti-obesity Medication) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Application
Figure 33. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2020-2025)
Figure 34. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application in 2025
Figure 35. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Application (2020-2025)
Figure 36. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Application in 2025
Figure 37. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2020-2025)
Figure 39. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region (2020-2025)
Figure 40. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country in 2024
Figure 43. North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country in 2024
Figure 45. U.S. Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Anti-Obesity Drugs (Anti-obesity Medication) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Anti-Obesity Drugs (Anti-obesity Medication) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country in 2024
Figure 53. Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country in 2024
Figure 55. Germany Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region in 2024
Figure 68. China Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (K MT)
Figure 79. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country in 2024
Figure 80. South America Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (M USD)
Figure 81. South America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country in 2024
Figure 82. Brazil Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region in 2024
Figure 92. Saudi Arabia Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Anti-Obesity Drugs (Anti-obesity Medication) Production Market Share by Region (2020-2025)
Figure 103. North America Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) Growth Rate (2020-2025)
Figure 106. China Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share Forecast by Type (2026-2035)
Figure 111. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Application (2026-2035)
Figure 112. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Anti-Obesity Drugs (Anti-obesity Medication)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD), 2025-2035
Figure 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) (2020-2035)
Figure 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Anti-Obesity Drugs (Anti-obesity Medication) Product Life Cycle
Figure 13. Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Manufacturers in 2025
Figure 14. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Manufacturers in 2025
Figure 15. Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Anti-Obesity Drugs (Anti-obesity Medication) Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Anti-Obesity Drugs (Anti-obesity Medication) Revenue in 2025
Figure 18. Industry Chain Map of Anti-Obesity Drugs (Anti-obesity Medication)
Figure 19. Global Anti-Obesity Drugs (Anti-obesity Medication) Market PEST Analysis
Figure 20. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Type
Figure 27. Sales Market Share of Anti-Obesity Drugs (Anti-obesity Medication) by Type (2020-2025)
Figure 28. Sales Market Share of Anti-Obesity Drugs (Anti-obesity Medication) by Type in 2025
Figure 29. Market Share of Anti-Obesity Drugs (Anti-obesity Medication) by Type (2020-2025)
Figure 30. Market Share of Anti-Obesity Drugs (Anti-obesity Medication) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Application
Figure 33. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2020-2025)
Figure 34. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application in 2025
Figure 35. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Application (2020-2025)
Figure 36. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Application in 2025
Figure 37. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2020-2025)
Figure 39. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region (2020-2025)
Figure 40. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country in 2024
Figure 43. North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country in 2024
Figure 45. U.S. Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Anti-Obesity Drugs (Anti-obesity Medication) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Anti-Obesity Drugs (Anti-obesity Medication) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country in 2024
Figure 53. Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country in 2024
Figure 55. Germany Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region in 2024
Figure 68. China Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (K MT)
Figure 79. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country in 2024
Figure 80. South America Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (M USD)
Figure 81. South America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country in 2024
Figure 82. Brazil Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region in 2024
Figure 92. Saudi Arabia Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Anti-Obesity Drugs (Anti-obesity Medication) Production Market Share by Region (2020-2025)
Figure 103. North America Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) Growth Rate (2020-2025)
Figure 106. China Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share Forecast by Type (2026-2035)
Figure 111. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Application (2026-2035)
Figure 112. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share Forecast by Application (2026-2035)
